Paul F. Killian
Advertisement
Articles by Paul F. Killian
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
SELLAS Cancer Vaccine Improves Overall Survival in Phase 3 AML Trial
2
The BioPharm Brief: A First for Streamlined Biosimilar Approval, a Head-to-Head Bispecific Trial in Wet AMD, and In Vivo KIR-CAR T
3
FDA Approves Cosentyx as First Anti-IL-17 Biologic for Polymyalgia Rheumatica
4
FDA Rejects Summit’s PD-1×VEGF Bispecific Ivonescimab in EGFR-Mutated NSCLC, Citing Lack of Survival Benefit
5

